Loading viewer...
conference
Format: PDF conference
S&P Global presented its 2016 results and strategic outlook at the Raymond James 38th Annual Institutional Investors Conference. The company highlighted strong revenue growth of 14% adjusted diluted EPS, 300 basis points of adjusted operating margin improvement, and progress on SNL integration synergies targeting $100 million by 2019. Key growth drivers include increased demand for real-time data and analytics, emerging market expansion, and index-related investments.
report
conference
132 Pages
Covestro
Tonix Pharmaceuticals TNX-102 SL Fibromyalgia 2024
conferenceconference
29 Pages
Tonix Pharmaceuticals Holding Corp.